C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $699,094 | -32.4% | 375,857 | 0.0% | 0.21% | -39.6% |
| Q2 2023 | $1,033,607 | -12.4% | 375,857 | 0.0% | 0.35% | -28.8% |
| Q1 2023 | $1,180,191 | -46.8% | 375,857 | 0.0% | 0.49% | -44.1% |
| Q4 2022 | $2,217,556 | -32.7% | 375,857 | 0.0% | 0.88% | -17.2% |
| Q3 2022 | $3,296,000 | +16.3% | 375,857 | 0.0% | 1.06% | +11.4% |
| Q2 2022 | $2,834,000 | -68.9% | 375,857 | 0.0% | 0.96% | -63.3% |
| Q1 2022 | $9,118,000 | -24.7% | 375,857 | 0.0% | 2.60% | -18.4% |
| Q4 2021 | $12,103,000 | – | 375,857 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |